Abstract
Neuromuscular transmission is mediated by nicotinic acetylcholine receptors for which various subtypes are described (Sargent 1993; McGehee and Role 1995; Karlin and Akabas 1995; Alexander et al. 2001).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Further Reading
General Considerations
Alexander S, Peters J, Mathie A, MacKenzie G, Smith A (2001) TiPS nomenclature supplement 2001
Allmark MG, Bachinski WM (1949) A method of assay for curare using rats. J Am Pharm Assoc 38:43–45
Burn JH, Finney DJ, Goodwin LG (1952) Biological standardization. Chapter XX, Curare-like compounds. Oxford University Press, London/New York/Toronto, pp 345–354
Collier HOJ, Hall RA, Fieller EC (1949) Use of a rotating drum in assessing the activities of paralysant, convulsant and anaesthetic drugs. Analyst 74:592–596
Fatt P, Katz B (1951) An analysis of the end-plate potential recorded with an intra-cellular electrode. J Physiol 115:320–370
Hoppe JO (1955) Observations on the potency of neuromuscular blocking agents with particular reference to succinylcholine. Anesthesiology 16:91–124
Hunter JM (1995) New neuromuscular blocking drugs. N Engl J Med 332:1691–1699
Karlin A, Akabas MH (1995) Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15:1231–1244
Levis S, Preat S, Dauby J (1953) Étude pharmacodynamique de deux séries de curarisants de synthèse. Arch Int Pharmacodyn Ther 93:46–54
McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521–546
Prior C, Dempster J, Marshall IG (1993) Electrophysiological analysis of transmission at the skeletal neuromuscular junction. J Pharmacol Toxicol Methods 30:1–17
Sargent PB (1995) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403–443
Savarese JJ, Antonio RP, Ginsburg S (1975) Potential uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments. Anesth Analg 54:669–678
Skinner HG, Young DM (1947) A mouse assay for curare. J Pharmacol Exp Ther 91:144–146
Varney RF, Linegar CR, Holaday HA (1948) The rabbit ‘head-drop’ method for the biological assay of curare and its alkaloids. Fed Proc 7:261–262
Varney RF, Linegar CR, Holaday HA (1949) The assay of curare by the rabbit ‘head-drop’ method. J Pharmacol Exp Ther 97:72–83
Zaimis E, Head S (1976) Depolarizing neuromuscular blocking drugs. In: Zaimis E (ed) Neuromuscular junction. Handbook of experimental pharmacology, vol 42. Springer, Berlin/Heidelberg/New York, pp 365–419
Isolated Phrenic Nerve Diaphragm Preparation of the Rat
Beani L, Bianchi C, Ledda F (1964) The effect of tubocurarine on acetylcholine release from motor nerve terminals. J Physiol 174:172–183
Birmingham AT, Hussain SZ (1980) A comparison of the skeletal neuromuscular and autonomic ganglion-blocking potencies of five non-depolarizing relaxants. Br J Pharmacol 70:501–506
Bülbring E (1946) Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmacol 1:38–61
Bülbring E, Chou TC (1947) The relative activity of prostigmine homologues and other substances as antagonists to tubocurarine. Br J Pharmacol 2:8–22
Chang CC, Chuang ST, Lee CY, Weio JW (1972) Role of cardiotoxin and phospholipase A in the blockade of nerve conduction and depolarization of skeletal muscle induced by cobra venom. Br J Pharmacol 44:752–764
Colbert WE, Wilson BF, Williams PD (1990) The effects of temperature on the experimental reliability of the isolated rat phrenic nerve/diaphragm preparation. J Pharmacol Meth 24:53–57
Hoppe JO (1955) Observations on the potency of neuromuscular blocking agents with particular reference to succinylcholine. Anesthesiology 16:91–124
Jenden DJ (1955) The effect of drugs upon neuromuscular transmission in the isolated guinea pig diaphragm. J Pharmacol Exp Ther 114:398–408
Jenden DJ, Kamijo K, Taylor DB (1994) The action of decamethonium on the isolated rabbit lumbrical muscle. J Pharmacol Exp Ther 111:229–240
Kojima M, Takagi H (1969) Effects of some anticholinergic drugs on antidromic activity in the rat phrenic nerve-diaphragm preparation. Eur J Pharmacol 5:161–167
Long JP, Chiou CY (1970) Pharmacological testing methods for drugs acting on the peripheral nervous system. J Pharm Sci 59:133–148
Muarata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H, Fukatsu Y, Isogaya M, Yamada N, Nishio S (1989) General pharmacology of beraprost sodium. 2nd communication: effects on the autonomic, cardiovascular and gastrointestinal systems, and other effects. Arzneimittelforschung 39:867–876
Muir AW, Houston J, Green KL, Marshall RJ, Bowman WC, Marshall IG (1989) Effects of a new neuromuscular blocking agent (ORG 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 63:400–410
Randic M, Straughan DM (1964) Antidromic activity in the rat phrenic nerve-diaphragm preparation. J Physiol 173:130–148
Thesleff S (1958) A study on the interaction between neuromuscular blocking agents and acetylcholine at the mammalian motor end-plate. Acta Anaesthesiol Scand 2:69–79
Van Riezen H (1968a) Classification of neuromuscular blocking agents in a new neuromuscular preparation of the chick in vitro. Eur J Pharmacol 5:29–36
Van Riezen H (1968b) Effect of cholinergic and anticholinergic drugs on a new neuromuscular preparation of the chick. Eur J Pharmacol 5:37–48
Vizi ES, Tuba Z, Maho S, Foldes FF, Nagano O, Doda M, Takagi S, Chaudhry IA, Saubermann AJ, Nagashima H (2003) A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side effects. Acta Anaesthesiol Scand 47:291–300
Wessler I, Kilbinger H (1986) Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol 334:357–364
Wessler I, Steinlein O (1987) Differential release of [3H]acetylcholine from the rat phrenic nerve-hemidiaphragm preparation by electrical nerve stimulation and by high potassium. Neuroscience 22:289–299
Wessler I, Wagner G, Walczok A (1992) Suppression by cholinesterase inhibition of a Ca2+-independent efflux of [3H]acetylcholine from the neuromuscular junction of the isolated rat diaphragm. Eur J Pharmacol 221:371–376
West GB (1947) Note on the biological assay of tubocurarine. Q J Pharm Pharmacol 20:518–527
Sciatic Nerve-Gastrocnemius Muscle Preparation in the Rabbit
Benz FW, Long JP (1969) Investigations on a series of heterocyclic hemicholinium-3 analogs. J Pharmacol Exp Ther 166:225–236
Bowman WC, Goldberg AAJ, Raper C (1962) A comparison between the effects of a tetanus and the effects of sympathomimetic amines on the fast- and slow-contracting mammalian muscles. Br J Pharmacol 19:464–484
Bülbring E, Chou TC (1947) The relative activity of prostigmine homologues and other substances as antagonists to tubocurarine. Br J Pharmacol 2:8–22
Chiou CY, Long JP (1969) Effects of α, α′-bis-(dimethylammoniumacetaldehyde diethylacetal)-p, p′-diacetylbiphenyl bromide (DMAE) on neuromuscular transmission. J Pharmacol Exp Ther 167:344–350
Durant NN, Bowman WC, Marshall IG (1977) A comparison of the neuromuscular and autonomic blocking activities of (+)-tubocurarine and its N-methyl and O, O, N-trimethyl analogues. Eur J Pharmacol 46:297–302
Levis S, Preat S, Dauby J (1953) Étude pharmacodynamique de deux séries de curarisants de synthèse. Arch Int Pharmacodyn Ther 93:46–54
Long JP, Evans CT, Wong S (1967) A pharmacological evaluation of hemicholinium analogs. J Pharmacol Exp Ther 155:223–230
MacIntosh (1938) The effect of preganglionic section on acetylcholine in the ganglion. J Physiol 92:22P
Paton WDM, Zaimis EJ (1948) Clinical potentialities of certain bisquarternary salts causing neuromuscular and ganglionic block. Nature 20:810
Paton WDM, Zaimis EJ (1951) The action of d-tubocurarine and of decamethonium on respiratory and other muscles in the cat. J Physiol 112:311–331
Reitzel NL, Long JP (1959) The neuromuscular properties of α,α′-dimethylamino-4,4′-biacetophenone (hemicholinium). Arch Int Pharmacodyn Ther 119:20–30
Salafsky B (1968) The effect of succinylcholine on denervated fast and slow skeletal muscle. Arch Int Pharmacodyn Ther 174:294–303
Wilson H, Long JP (1959) Effect of hemicholinium (HC-3) at various peripheral cholinergic transmitting sites. Arch Int Pharmacodyn Ther 120:343–352
Evaluation of Neuromuscular Blockade in Cats, Pigs, Dogs and Monkeys
Bowman WC, Rodger IW, Houston J, Marshall RJ, McIndewar I (1988) Structure: action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 69:57–62
Brown KM, Dennis JS (1972) Derivative free analogs of the Levenberg-Marquardt and Gauss algorithms for non-linear least square approximation. Numer Math 18:288–297
Clutton RE, Boyd C, Flora R, Payne J, McGrath CJ (1992) Autonomic and cardiovascular effects of neuromuscular blockade antagonism in the dog. Vet Surg 21:68–75
Cullen LK, Jones RS, Snowdon SL (1980) Neuromuscular activity in the intact dog: techniques for recording evoked mechanical responses. Br Vet J 136:154–159
Hoppe JO (1950) A pharmacological investigation of 2,5-bis-(3-diethylaminopropylamino)benzoquinone-bis-benzylchloride (WIN 2747) A new curarimimetic drug. J Pharmacol Exp Ther 100:333–345
Hughes R (1984) Experimental and clinical evaluation of neuromuscular blocking agents. J Pharmacol Meth 12:1–27
Hughes R, Chapple DJ (1976a) Effects of non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Br J Anaesth 48:59–68
Hughes R, Chapple DJ (1976b) Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys. Br J Anaesth 48:847–852
Hughes R, Chapple DJ (1981) The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Pharmacol 53:31–44
Keesey JC (1988) AAEE minimonograph33: electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve 12:613–626
Khuenl-Brady K, Castagnoli KP, Canfell PC, Caldwell JE, Agoston S, Miller RD (1990) The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Anesthesiology 72:669–674
Marshall RJ, Muir AW, Sleigh T, Savage DS (1994) An overview of the pharmacology of rocuronmium bromide in experimental animals. Eur J Anaesthesiol 11(Suppl 9):9–15
Muir AW, Houston J, Green KL, Marshall RJ, Bowman WC, Marshall IG (1989) Effects of a new neuromuscular blocking agent (ORG 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 63:400–410
Muir AW, Anderson K, Marshall RJ, Booij LHDJ, Crul FJ, Prior C, Bowman WC, Marshall IG (1991) The effects of a 16-N-homopyridine analogue of vecuronium in anesthetized cats, pigs, dogs and monkeys, and in isolated preparations. Acta Anaesthesiol Scand 35:85–90
Ono H, Saito KI, Kondo M, Morishita SI, Kato K, Hasebe Y, Nakayama M, Kato F, Nakamura T, Satoh M, Oka JI, Goto M, Fukuda H (1990) Effects of the new centrally acting muscle relaxant 7-chloro-N,N,3-trimethylbenzo[b]furan-2-carboxamide on motor and central nervous systems in rats. Arzneimittelforschung 40:730–735
Paton WDM (1957) Histamine release by compounds of simple chemical structure. Pharmacol Rev 9:269–328
Savarese JJ (1979) The autonomic margins of safety of metocurine and d-tubocurarine in the cat. Anesthesiology 50:40–46
Walts LF (1973) The “Boomerang” – a method for recording adductor pollicis tension. Can Anaesth Soc J 20:706–708
Evaluation of Neuromuscular Blockade in Anesthetized Mice
Cullen LK, Jones RS, Snowdon SL (1980) Neuromuscular activity in the intact dog: techniques for recording evoked mechanical responses. Br Vet J 136:154–159
Keesey JC (1989) AAEE Minimonograph 33: electrodiagnosis approach to defects of neuromuscular transmission. Muscle Nerve 12:613–626
Lefebvre HP, Cardona A, Toutain PL, Morel E, Bach JF, Vernetder-Garabedian B (1992) A simple method for the quantitative evaluation of neuromuscular blockade in mice. J Pharmacol Toxicol Methods 27:129–133
Safety Pharmacology
Vogel HG (2006) Chapter I.H. Peripheral nervous system. In: Vogel HG, Hock FJ, Maas J, Mayer D (eds) Drug discovery and evaluation safety and pharmacokinetic assays. Springer, Berlin/Heidelberg/New York, pp 195–209
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Hartung, HP. (2016). Neuromuscular Blocking Activity. In: Hock, F. (eds) Drug Discovery and Evaluation: Pharmacological Assays. Springer, Cham. https://doi.org/10.1007/978-3-319-05392-9_39
Download citation
DOI: https://doi.org/10.1007/978-3-319-05392-9_39
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-05391-2
Online ISBN: 978-3-319-05392-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences